Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Cancer-associated TERT promoter mutations abrogate telomerase silencing.

TERT promoter mutations and monoallelic activation of TERT in cancer.

TERT promoter mutations in thyroid cancer.

TERT promoter mutations in cancer development.

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications.

Association of TERT promoter mutations with telomerase expression in melanoma.

Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients.

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.

Reactivation of telomerase in cancer.

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

TERT promoter mutations predict worse survival in laryngeal cancer patients.

The absence of TERT promoter mutations in primary gastric cancer.

TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.

TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.

Recurrence in Papillary Thyroid Cancer.

Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report.

TERT Promoter Mutations and Risk of Recurrence in Meningioma.

ARID1A and TERT promoter mutations in dedifferentiated meningioma.

P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.

TERT Promoter Mutations Promote Immortalization and Genomic Instability.

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.

Suggest Documents

Cancer-associated TERT promoter mutations abrogate telomerase silencing.

TERT promoter mutations and monoallelic activation of TERT in cancer.

TERT promoter mutations in thyroid cancer.

TERT promoter mutations in cancer development.

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications.

Association of TERT promoter mutations with telomerase expression in melanoma.

Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients.

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.

Reactivation of telomerase in cancer.

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

TERT promoter mutations predict worse survival in laryngeal cancer patients.

The absence of TERT promoter mutations in primary gastric cancer.

TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.

TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.

Recurrence in Papillary Thyroid Cancer.

Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report.

TERT Promoter Mutations and Risk of Recurrence in Meningioma.

ARID1A and TERT promoter mutations in dedifferentiated meningioma.

P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.

TERT Promoter Mutations Promote Immortalization and Genomic Instability.

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.

Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Recommend Documents

Follow Us